Sun Pharma Inds. - Quarterly Results
2nd Nov 2021

A fair growth of 17.34% in the revenue at Rs. 41431.50 millions was reported in the September 2021 quarter as compared to Rs. 35309.70 millions during year-ago period.Net Profit for the quarter ended September 2021 zoomed to 261.68% from Rs. 2237.00 millions to Rs. 8090.70  millions.OP of the company witnessed a marginal growth to 11485.40 millions from 5228.70 millions in the same quarter last year.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 41431.50 35309.70 17.34 74691.00 64940.10 15.02 128032.10 125319.30 2.16
Other Income 2842.70 835.60 240.20 4833.90 1608.90 200.45 1502.20 15109.20 -90.06
PBIDT 11485.40 5228.70 119.66 18378.30 12660.80 45.16 30862.20 42225.70 -26.91
Interest 1039.80 161.30 544.64 2097.00 850.30 146.62 2569.80 4080.10 -37.02
PBDT 10445.60 5067.40 106.13 16281.30 11810.50 37.85 27396.80 38145.60 -28.18
Depreciation 3336.40 3059.70 9.04 4845.60 4487.60 7.98 5868.10 5615.60 4.50
PBT 7109.20 2007.70 254.10 11435.70 7322.90 56.16 21528.70 32530.00 -33.82
TAX -981.50 -229.30 328.04 -848.00 -233.60 263.01 131.70 418.60 -68.54
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 8090.70 2237.00 261.68 12283.70 7556.50 62.56 21397.00 32111.40 -33.37
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 27.72 14.81 87.20 24.61 19.50 26.21 24.11 33.69 -28.46